Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Sol…
Medical - Diagnostics & Research
US, Waltham [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -3.34 | 1.70 | 1.75 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -18.65 | 11.78 | 14.48 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -1.31 | 119.15 | 120.73 | |
| Cash | -8.98 | 19.00 | 20.87 | |
| Capex | 13.20 | -0.91 | -1.05 | |
| Free Cash Flow | -72.40 | 2.37 | 8.57 | |
| Revenue | -3.73 | 27.08 | 28.13 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -1.30 | 0.41 | 0.41 | |
| Operating Margin | -2.38 | 0.17 | 0.17 | |
| ROA | -17.16 | 0.01 | 0.02 | |
| ROE | -16.37 | 0.03 | 0.03 | |
| ROIC | -28.60 | 0.02 | 0.02 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of TMO is permitted for members.
5
Growth
The "Growth Entry" for the Focus of TMO is permitted for members.
6
Leverage & Liquidity